Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ CDK8 Recombinant Rabbit Monoclonal Antibody (7L5X2)
CDK8 Recombinant Rabbit Monoclonal Antibody (ARC1682)
Supplier: Invitrogen™ MA535830
Description
CDK8 Recombinant Monoclonal Antibody for Western Blot
CDK8 phosphorylates the carboxy-terminal domain of the largest subunit of RNA polymerase II. This protein is coexpressed and copurified with Cyclin C. CDK8 is part of a family of proteins designated as cdks are critical regulators of cell cycle progression. The prototype member of this family, p34/Cdc 2, and a related protein Cdk 2, function late in the cycle while Cdk 4 and Cdk 6 are critically involved in G1 to S progression. Because of analogy with yeast Cdk 8, it has been proposed that the human Cdk 8 Cyclin C may interact with RNA polymerase, thus influencing the transcription mechanism(s) that lead to cell division.
Specifications
CDK8 | |
Recombinant Monoclonal | |
0.8 mg/mL | |
PBS with 0.05% BSA, 50% glycerol and 0.02% sodium azide; pH 7.3 | |
Q8R3L8 | |
Cdk8 | |
A synthetic peptide corresponding to a sequence within amino acids 1-100 of human CDK8 (P49336). | |
100 μL | |
Primary | |
Mouse, Rat | |
Antibody | |
IgG |
ELISA, Western Blot | |
7L5X2 | |
Unconjugated | |
Cdk8 | |
Cdk8; CDK8 protein kinase; cell division protein kinase 8; Cell division protein kinase 8-like protein; cyclin dependent kinase 8; cyclin-dependent kinase 8; K35; mediator complex subunit CDK8; Mediator of RNA polymerase II transcription subunit CDK8; MGC126074; MGC126075; protein kinase K35; RGD1560888; wu:fk95h11 | |
Rabbit | |
Affinity chromatography | |
RUO | |
264064, 498140 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction